MLR-1023

MLR-1023 · Melior Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MLR-1023, covering 2019-01-09 to 2019-01-09. Get the full timeline:

Most recent: Clinical Trial Update: An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy [Phase 2]